Notable Analyst Upgrades and Downgrades (NYSE: WBC) (TSX: DW)

Published:

A Canadian gold project developer and a U.S. bank holding company both received analyst upgrades, one of which has an implied upside of nearly 50%.

The following stocks were upgraded/downgraded on September 25, 2014
Company Name Exchange Ticker Last Price Market Cap Recommendation Analyst Name Rating Company Target Price Upside/
Downside (%)
DataWind Inc TSX DW 3.30 72.5 Initiate with speculative buy Hubert Mak Cormark Securities Inc. 6.50 97.0%
Intertain Group Ltd/The TSX IT 11.25 276.0 Initiate with buy Nikhil Thadani Mackie Research Capital Corp. 14.00 24.4%
Manitoba Telecom Services Inc TSX MBT 29.15 2,266.7 Downgrade to underweight from equalweight Phillip Huang Barclays 28.00 -3.9%
Stantec Inc TSX STN 71.60 3,350.9 Downgrade to hold from buy Michael Tupholme TD Securities 83.00 15.9%
Finning International Inc TSX FTT 31.96 5,504.6 Downgrade to market perform from outperform Ben Cherniavsky Raymond James 34.50 7.9%

Cormark Securities Inc. initiated coverage on DataWind Inc (TSX: DW), engaged in providing wireless Web access products and services, with a speculative buy rating assigning a 12-months price target of C$6.50, indicating an upside potential of 97.0% from current levels.

Coverage on Intertain Group Ltd (TSX: IT), engaged in offering a range of internet gaming solutions, was initiated with a buy rating at Mackie Research Capital Corp., assigning a 12-months price target of C$14.00, indicating an upside potential of 24.4% from current levels.

Barclays downgraded Manitoba Telecom Services Inc (TSX: MBT), engaged in providing full-service telecommunications, to underweight from equal weight by reducing its price target to C$28.00 from C$29.00, indicating a downside of 3.9% from current levels.

Stantec Inc (TSX: STN), engaged in providing professional consulting services in the area of infrastructure and facilities for clients in the public and private sectors, was downgraded by TD Securities to hold from buy with a price target of C$83.00, implying an upside potential of 15.9% from current levels.

Raymond James downgraded Finning International Inc (TSX: FTT), engaged in selling, financing, and servicing Caterpillar and complementary equipment, to market perform from outperform with a price target of C$34.50, indicating an upside of 7.9% from current levels. According to the rating firm, uncertainty in global commodity markets and lengthy timeline for value creating initiatives caused stock downgrade.

The following stocks were upgraded/downgraded on September 25, 2014
Company Name Exchange Ticker Last Price Market Cap Recommendation Analyst Name Rating Company Target Price Upside/
Downside (%)
WABCO Holdings Inc NYSE WBC 93.22 5,574.0 Upgrade to buy from hold Michael J Baudendistel Stifel 111.00 19.1%
Lennox International Inc NYSE LII 78.02 3,789.6 Upgrade to buy from neutral Joshua C Pokrzywinski Buckingham Research Group 93.00 19.2%
ARC Document Solutions Inc NYSE ARC 7.01 327.2 Initiate with buy Matt Blazei Lake Street Capital Markets LLC 11.00 56.9%
Auspex Pharmaceuticals Inc NASDAQ ASPX 22.67 619.8 Initiate with buy Robert C Hazlett Ladenburg Thalmann & Co 37.00 63.2%
HB Fuller Co NYSE FUL 37.68 1,892.1 Downgrade to neutral from overweight Mike J Ritzenthaler Piper Jaffray 42.00 11.5%

Stifel upgraded WABCO Holdings Inc (NYSE: WBC), a provider of electronic, mechanical and mechatronic products for the commercial truck, trailer, bus and passenger car manufacturers, to buy from hold with a price target of $111.00, indicating an upside of 19.1% from current levels.

Lennox International Inc (NYSE: LII), engaged in providing climate control solutions, was upgraded by Buckingham Research Group to buy from neutral with a price target of $93.00, indicating an upside potential of 19.2% from current levels.

Lake Street Capital Markets LLC initiated coverage on ARC Document Solutions Inc (NYSE: ARC), engaged in providing services that include scanning, imaging, and managing black and white and color documents, with a buy rating assigning a 12-months price target of $11.00, indicating an upside potential of 56.9% from current levels.

Coverage on Auspex Pharmaceuticals Inc (NASDAQ: ASPX), engaged in the development and commercialization of medicines for the treatment of orphan diseases, was initiated with a buy rating at Ladenburg Thalmann & Co, assigning a 12-months price target of $37.00, indicating an upside potential of 63.2% from current levels.

HB Fuller Co (NYSE: FUL), engaged in manufacturing and marketing of adhesives, sealants and other specialty chemical products, was downgraded by Piper Jaffray to neutral from overweight by reducing its price target to $42.00 from $54.00, implying an upside potential of 11.5% from current levels.

Related articles

Recent articles